Kilitch Drugs

{
  "main_header": {
    "sid": 189669,
    "name": "Kilitch Drugs",
    "stock_name": "Kilitch Drugs",
    "full_name": "Kilitch Drugs (India) Ltd",
    "name_url": "stocks-analysis/kilitch-drugs",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "195.50",
    "chg": 9.15,
    "chgp": "4.91%",
    "dir": 1,
    "prev_price": "186.35",
    "mcapval": "663.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524500,
    "symbol": "KILITCH",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE729D01010",
    "curr_date": "Jun 30, 03:30 PM",
    "curr_time": "22:52 PM",
    "last_traded_at": "Jun 30, 03:30 PM IST",
    "bse_nse_vol": "1.95 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 30, 2026",
    "traded_date_str": "2026 06 30",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/kilitch-drugs-189669-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Kilitch Drugs Forms Golden Cross Amid Mixed Technical Signals and Strong Recent Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-forms-golden-cross-signalling-potential-bullish-breakout-4079466",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/KilitchDrugsInd_goldencross_4079466.png",
        "date": "2026-06-30 18:45:18",
        "description": "The 50-day moving average for Kilitch Drugs (India) Ltd has crossed above the 200-day moving average, signalling a golden cross on 30 Jun 2026. Yet, this technical event arrives amid a complex backdrop of mixed momentum indicators and a micro-cap status, raising questions about the signal’s reliability in isolation."
      },
      {
        "title": "Kilitch Drugs (India) Ltd Technical Momentum Shifts Signal Mildly Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-india-ltd-technical-momentum-shifts-signal-mildly-bullish-outlook-4072332",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/KilitchDrugsInd_technicaldot_4072332.png",
        "date": "2026-06-25 08:00:35",
        "description": "Kilitch Drugs (India) Ltd has exhibited a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bullish stance. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, suggesting cautious optimism for investors in this micro-cap pharmaceutical stock."
      },
      {
        "title": "Kilitch Drugs (India) Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kilitch-drugs-india-ltd-is-rated-hold-by-marketsmojo-4065017",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/KilitchDrugsInd_mojoScore_4065017.png",
        "date": "2026-06-20 10:10:42",
        "description": "Kilitch Drugs (India) Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Kilitch Drugs (India) Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-india-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4053342",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/KilitchDrugsInd_technicaldot_4053342.png",
        "date": "2026-06-15 08:00:44",
        "description": "Kilitch Drugs (India) Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more sideways trend, reflecting a complex interplay of bullish and bearish signals across key technical indicators. The stock’s recent 4.06% daily gain to ₹188.40, coupled with a significant upgrade in its Mojo Grade from Sell to Hold, underscores evolving investor sentiment in the Pharmaceuticals & Biotechnology micro-cap space."
      },
      {
        "title": "Kilitch Drugs Falls 4.11%: 4 Key Technical and Financial Factors Driving the Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-falls-411-4-key-technical-and-financial-factors-driving-the-decline-4053140",
        "imagepath": "",
        "date": "2026-06-14 15:02:16",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>1 Jun:</strong> Mojo Grade downgraded to Sell amid mixed financials and bearish technicals</p>\n                    <p><strong>2 Jun:</strong> Technical momentum shifts to mildly bearish with mixed indicator signals</p>\n                    <p><strong>3 Jun:</strong> Technical trend moves sideways, signalling consolidation</p>\n                    <p><strong>4 Jun:</strong> Price momentum turns mildly bearish amid mixed technical signals</p>\n                    <p><strong>5 Jun:</strong> Week closes at ₹173.70, down 4.11% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><..."
      },
      {
        "title": "Kilitch Drugs Gains 8.46%: 5 Key Factors Driving the Week’s Mixed Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-gains-846-5-key-factors-driving-the-weeks-mixed-momentum-4051638",
        "imagepath": "",
        "date": "2026-06-13 14:10:58",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>8 June:</strong> Technical momentum shifts to mildly bearish; stock closes at ₹167.20 (-3.74%)</p>\n                    <p><strong>9 June:</strong> Mojo rating upgraded to Hold; stock surges 12.80% to ₹188.60</p>\n                    <p><strong>10 June:</strong> Valuation shifts to fair amid strong market performance; stock dips 2.73% to ₹183.45</p>\n                    <p><strong>11 June:</strong> Technical momentum moves to sideways; stock declines 1.31% to ₹181.05</p>\n                    <p><strong>12 June:</strong> Technical momentum shifts back to mildly bearish; stock rebounds 4.06% to close at ₹188.40</p>\n                </div>\n\n                <div class=\"stats-row\">\n        ..."
      },
      {
        "title": "Kilitch Drugs (India) Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-india-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4048199",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/KilitchDrugsInd_technicaldot_4048199.png",
        "date": "2026-06-12 08:00:39",
        "description": "Kilitch Drugs (India) Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a recent downgrade in daily moving averages and on-balance volume, weekly and monthly indicators present a complex picture, reflecting both bullish and bearish signals. This nuanced technical landscape warrants close attention from investors seeking to understand the stock’s near-term trajectory within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Kilitch Drugs (India) Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-india-ltd-technical-momentum-shifts-amid-mixed-market-signals-4045726",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/KilitchDrugsInd_technicaldot_4045726.png",
        "date": "2026-06-11 08:00:45",
        "description": "Kilitch Drugs (India) Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more sideways trend, reflecting a complex interplay of bullish and bearish signals across key indicators. Despite a recent downgrade in daily moving averages and a 2.73% decline in the latest session, the stock’s weekly and monthly technicals reveal a nuanced picture that investors should carefully analyse."
      },
      {
        "title": "Kilitch Drugs Valuation Shifts to Fair Amidst Strong Market Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-valuation-shifts-to-fair-amidst-strong-market-performance-4043104",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/KilitchDrugsInd_valuationdot_4043104.png",
        "date": "2026-06-10 08:00:11",
        "description": "Kilitch Drugs (India) Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to a fair valuation grade, reflecting evolving market perceptions amid a volatile Pharmaceuticals & Biotechnology sector. This recalibration comes alongside a significant 12.8% surge in the stock price, prompting investors to reassess its price attractiveness relative to historical and peer benchmarks."
      }
    ],
    "total": 336,
    "sid": "189669",
    "stock_news_url": "https://www.marketsmojo.com/news/kilitch-drugs-india-189669"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "26-Jun-2026",
      "details": "We are submitting herewith the intimation of Closure of window",
      "source": "BSE"
    },
    {
      "caption": "Announcement Under Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015 - Commencement Of Nutraceutical Manufacturing Block Of Our New Plant",
      "datetime": "17-Jun-2026",
      "details": "We are pleased to inform you that we have commenced the Nutraceutical Manufacturing Block of our new plant located at 24/2/1/1 Maldev Pen Raigad Maharashtra India today. i.e 17th June 2026",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "27-May-2026",
      "details": "We are hereby submitting annual secretarial compliance report for the year ended 31st March 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Kilitch Drugs (India) Ltd has declared <strong>5%</strong> dividend, ex-date: 20 Sep 19",
          "dt": "2019-09-20",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Kilitch Drugs (India) Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 24 Mar 26",
          "dt": "2026-03-24",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Kilitch Drugs (India) Ltd has announced <strong>2:23</strong> rights issue, ex-date: 15 Jul 25",
          "dt": "2025-07-15",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Kilitch Drugs Forms Golden Cross Amid Mixed Technical Signals and Strong Recent Rally

2026-06-30 18:45:18

The 50-day moving average for Kilitch Drugs (India) Ltd has crossed above the 200-day moving average, signalling a golden cross on 30 Jun 2026. Yet, this technical event arrives amid a complex backdrop of mixed momentum indicators and a micro-cap status, raising questions about the signal’s reliability in isolation.

Read full news article

Kilitch Drugs (India) Ltd Technical Momentum Shifts Signal Mildly Bullish Outlook

2026-06-25 08:00:35

Kilitch Drugs (India) Ltd has exhibited a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bullish stance. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, suggesting cautious optimism for investors in this micro-cap pharmaceutical stock.

Read full news article

Kilitch Drugs (India) Ltd is Rated Hold by MarketsMOJO

2026-06-20 10:10:42

Kilitch Drugs (India) Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Kilitch Drugs (India) Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-06-15 08:00:44

Kilitch Drugs (India) Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more sideways trend, reflecting a complex interplay of bullish and bearish signals across key technical indicators. The stock’s recent 4.06% daily gain to ₹188.40, coupled with a significant upgrade in its Mojo Grade from Sell to Hold, underscores evolving investor sentiment in the Pharmaceuticals & Biotechnology micro-cap space.

Read full news article

Kilitch Drugs Falls 4.11%: 4 Key Technical and Financial Factors Driving the Decline

2026-06-14 15:02:16

Key Events This Week

1 Jun: Mojo Grade downgraded to Sell amid mixed financials and bearish technicals

2 Jun: Technical momentum shifts to mildly bearish with mixed indicator signals

3 Jun: Technical trend moves sideways, signalling consolidation

4 Jun: Price momentum turns mildly bearish amid mixed technical signals

5 Jun: Week closes at ₹173.70, down 4.11% for the week

Week Open

<...

Read full news article

Kilitch Drugs Gains 8.46%: 5 Key Factors Driving the Week’s Mixed Momentum

2026-06-13 14:10:58

Key Events This Week

8 June: Technical momentum shifts to mildly bearish; stock closes at ₹167.20 (-3.74%)

9 June: Mojo rating upgraded to Hold; stock surges 12.80% to ₹188.60

10 June: Valuation shifts to fair amid strong market performance; stock dips 2.73% to ₹183.45

11 June: Technical momentum moves to sideways; stock declines 1.31% to ₹181.05

12 June: Technical momentum shifts back to mildly bearish; stock rebounds 4.06% to close at ₹188.40

...

Read full news article

Kilitch Drugs (India) Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-06-12 08:00:39

Kilitch Drugs (India) Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a recent downgrade in daily moving averages and on-balance volume, weekly and monthly indicators present a complex picture, reflecting both bullish and bearish signals. This nuanced technical landscape warrants close attention from investors seeking to understand the stock’s near-term trajectory within the Pharmaceuticals & Biotechnology sector.

Read full news article

Kilitch Drugs (India) Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-06-11 08:00:45

Kilitch Drugs (India) Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more sideways trend, reflecting a complex interplay of bullish and bearish signals across key indicators. Despite a recent downgrade in daily moving averages and a 2.73% decline in the latest session, the stock’s weekly and monthly technicals reveal a nuanced picture that investors should carefully analyse.

Read full news article

Kilitch Drugs Valuation Shifts to Fair Amidst Strong Market Performance

2026-06-10 08:00:11

Kilitch Drugs (India) Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to a fair valuation grade, reflecting evolving market perceptions amid a volatile Pharmaceuticals & Biotechnology sector. This recalibration comes alongside a significant 12.8% surge in the stock price, prompting investors to reassess its price attractiveness relative to historical and peer benchmarks.

Read full news article

View All News